Inflammation and Cachexia in Chronic Kidney Disease

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2010 Jan 30

PMID 20111974

Citations 71

Authors

Wai W Cheung

Kyung Hoon Paik

Robert H Mak

Affiliations

Soon will be listed here.

Abstract

Chronic inflammation is associated with cachexia and increased mortality risk in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Inflammation suppresses appetite and causes the loss of protein stores. In CKD patients, increased serum levels of pro-inflammatory cytokines may be caused by reduced renal function, volume overload, oxidative or carbonyl stress, decreased levels of antioxidants, increased susceptibility to infection in uremia, and the presence of comorbid conditions. Cachexia is brought about by the synergistic combination of a dramatic decrease in appetite and an increase in the catabolism of fat and lean body mass. Pro-inflammatory cytokines act on the central nervous system to alter appetite and energy metabolism and to provide a signal-through the nuclear factor-kappaB and ATP-ubiquitin-dependent proteolytic pathways-that causes muscle wasting. Further research into the molecular pathways leading to inflammation and cachexia may lead to novel therapeutic therapies for this devastating and potentially fatal complication of chronic disease.

Citing Articles

Combating chronic kidney disease-associated cachexia: A literature review of recent therapeutic approaches.

Rahbar Saadat Y, Abbasi A, Hejazian S, Hekmatshoar Y, Ardalan M, Farnood F BMC Nephrol. 2025; 26(1):133.

PMID: 40069669 PMC: 11895341. DOI: 10.1186/s12882-025-04057-8.

Characteristics of soybean () protein hydrolysate by bromelain and its effect on inflammation and kidney disorders in gentamicin-induced male Wistar rats.

Hidayat M, Barnas A, Nussy V, Wantania T, Prahastuti S, Sriwidodo S Iran J Basic Med Sci. 2025; 28(1):56-62.

PMID: 39877638 PMC: 11771338. DOI: 10.22038/ijbms.2024.78131.16885.

The lived experience of renal cachexia: An interpretive phenomenological analysis.

Blair C, Shields J, Mullan R, Johnston W, Davenport A, Fouque D Int J Nurs Stud Adv. 2024; 7:100235.

PMID: 39328835 PMC: 11426076. DOI: 10.1016/j.ijnsa.2024.100235.

Regulation of Satellite Cells Functions during Skeletal Muscle Regeneration: A Critical Step in Physiological and Pathological Conditions.

Careccia G, Mangiavini L, Cirillo F Int J Mol Sci. 2024; 25(1).

PMID: 38203683 PMC: 10778731. DOI: 10.3390/ijms25010512.

Editorial: Immunology of cachexia.

Kumar V, Stewart 4th J Front Immunol. 2023; 14:1339263.

PMID: 38116001 PMC: 10728869. DOI: 10.3389/fimmu.2023.1339263.

References

Sietsema K, Hiatt W, Esler A, Adler S, Amato A, Brass E . Clinical and demographic predictors of exercise capacity in end-stage renal disease. Am J Kidney Dis. 2002; 39(1):76-85. DOI: 10.1053/ajkd.2002.29884. View

Merino A, Nogueras S, Buendia P, Ojeda R, Carracedo J, Ramirez-Chamond R . Microinflammation and endothelial damage in hemodialysis. Contrib Nephrol. 2008; 161:83-88. DOI: 10.1159/000130412. View

Wanner C, Zimmermann J . Causes of coronary heart disease in patients on renal replacement therapy. Kidney Blood Press Res. 1998; 21(2-4):287-9. DOI: 10.1159/000025881. View

Stenvinkel P . New insights on inflammation in chronic kidney disease-genetic and non-genetic factors. Nephrol Ther. 2006; 2(3):111-9. DOI: 10.1016/j.nephro.2006.04.004. View

Verma S, Kuliszewski M, Li S, Szmitko P, Zucco L, Wang C . C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation. 2004; 109(17):2058-67. DOI: 10.1161/01.CIR.0000127577.63323.24. View

Suffredini A, Fantuzzi G, Badolato R, Oppenheim J, OGrady N . New insights into the biology of the acute phase response. J Clin Immunol. 1999; 19(4):203-14. DOI: 10.1023/a:1020563913045. View

Wilson A, de Vries N, Pociot F, Di Giovine F, van der Putte L, Duff G . An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 1993; 177(2):557-60. PMC: 2190902. DOI: 10.1084/jem.177.2.557. View

Bossola M, Muscaritoli M, Costelli P, Nanni G, Tazza L, Panocchia N . Muscle ubiquitin m-rNA levels in patients with end-stage renal disease on maintenance hemodialysis. J Nephrol. 2002; 15(5):552-7. View

Wyke S, Russell S, Tisdale M . Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation. Br J Cancer. 2004; 91(9):1742-50. PMC: 2409951. DOI: 10.1038/sj.bjc.6602165. View

10.

Sun D, Chen Y, Rabkin R . Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia. Kidney Int. 2006; 70(3):453-9. DOI: 10.1038/sj.ki.5001532. View

11.

Pickering W, Price S, Bircher G, Marinovic A, Mitch W, Walls J . Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int. 2002; 61(4):1286-92. DOI: 10.1046/j.1523-1755.2002.00276.x. View

12.

Poole S, Bird T, Selkirk S, Gaines-Das R, Choudry Y, Stephenson S . Fate of injected interleukin 1 in rats: sequestration and degradation in the kidney. Cytokine. 1990; 2(6):416-22. DOI: 10.1016/1043-4666(90)90050-4. View

13.

Tatidis L, Vitols S, Gruber A, Paul C, Axelson M . Cholesterol catabolism in patients with acute myelogenous leukemia and hypocholesterolemia: suppressed levels of a circulating marker for bile acid synthesis. Cancer Lett. 2001; 170(2):169-75. DOI: 10.1016/s0304-3835(01)00592-4. View

14.

Guttridge D, Mayo M, Madrid L, Wang C, Baldwin Jr A . NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science. 2000; 289(5488):2363-6. DOI: 10.1126/science.289.5488.2363. View

15.

Cai D, Frantz J, Tawa Jr N, Melendez P, Oh B, Lidov H . IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell. 2004; 119(2):285-98. DOI: 10.1016/j.cell.2004.09.027. View

16.

Yee-Moon Wang A, Wang M, Woo J, Law M, Chow K, Kam-Tao Li P . A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int. 2002; 62(2):639-47. DOI: 10.1046/j.1523-1755.2002.00471.x. View

17.

Ruan X, Varghese Z, Powis S, Moorhead J . Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int. 2001; 60(5):1716-25. DOI: 10.1046/j.1523-1755.2001.00025.x. View

18.

Mak R, Cheung W, Cone R, Marks D . Leptin and inflammation-associated cachexia in chronic kidney disease. Kidney Int. 2006; 69(5):794-7. DOI: 10.1038/sj.ki.5000182. View

19.

Jenkins D, Kendall C, Marchie A, Faulkner D, Josse A, Wong J . Direct comparison of dietary portfolio vs statin on C-reactive protein. Eur J Clin Nutr. 2005; 59(7):851-60. PMC: 7073252. DOI: 10.1038/sj.ejcn.1602152. View

20.

Ladner K, Caligiuri M, Guttridge D . Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products. J Biol Chem. 2002; 278(4):2294-303. DOI: 10.1074/jbc.M207129200. View